Proteomic Dissection of Withdrawal-Induced Excessive Drinking

戒断引起的过度饮酒的蛋白质组学解析

基本信息

  • 批准号:
    7672576
  • 负责人:
  • 金额:
    $ 24.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-30 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chronic exposure to alcohol results in neuroadaptive phenomena, including tolerance, sensitization, dependence, withdrawal, loss of control of drinking, and relapse that contribute to the development of excessive alcohol consumption. The goal of the INIA (Integrative Neuroscience Initiative on Alcoholism) Consortium is to identify the molecular, cellular, and behavioral neuroadaptations that occur in the brain reward circuits associated with the extended amygdala and its connections. It is hypothesized that genetic differences and/or neuroadaptations in this circuitry are responsible for the individual differences in vulnerability to the excessive consumption of alcohol. We propose to use quantitative proteomics to dissect the molecular mechanisms contributing to the behavioral phenotype of differential and excessive drinking (both baseline drinking and withdrawal induced drinking) in two animal models: 1) Adenylyl Cyclase 7 (AC7) transgenic animals - changes in the copy number of the AC7 gene produces changes in drinking phenotype using the Withdrawal Induced Drinking (WID) paradigm and 2) High Alcohol Preference (HAP)/Low Alcohol Preference (LAP) animals - animals selectively bred for differences in free-choice alcohol consumption by the 2 Bottle-Choice (2BC) paradigm - the selected genotype (changes in multiple genes) contributes to differential baseline drinking. Our goals are 1) to develop and optimize proteomic methodology for the quantitative analysis of enriched brain fractions, 2) to identify global differences in baseline protein expression between selected lines of the two animal models [AC7 transgenic model (AC7 transgenic versus wildtype) and HAP/LAP selective breeding model (HAP versus LAP)], and 3) to globally compare longitudinal changes in protein expression between animals (AC7 transgenic versus wildtype and HAP versus LAP) at selected time points during WID-2BC to identify proteins that contribute to the differential and excessive drinking behaviors.
描述(由申请人提供):长期接触酒精会导致神经适应现象,包括耐受、敏感、依赖、戒断、饮酒失控和复发,从而导致过量饮酒。 INIA(酒精中毒综合神经科学倡议)联盟的目标是确定与扩展杏仁核及其连接相关的大脑奖赏回路中发生的分子、细胞和行为神经适应。据推测,该回路中的遗传差异和/或神经适应是造成过度饮酒易感性的个体差异的原因。我们建议使用定量蛋白质组学来剖析两种动物模型中导致差异和过度饮酒(基线饮酒和戒断诱导饮酒)行为表型的分子机制:1)腺苷酸环化酶 7 (AC7) 转基因动物 - 拷贝的变化AC7 基因的数量使用戒断诱导饮酒 (WID) 范式和 2) 高酒精偏好 (HAP)/低酒精偏好产生饮酒表型的变化(LAP) 动物 - 通过 2 Bottle-Choice (2BC) 范式针对自由选择酒精消耗差异进行选择性培育的动物 - 选定的基因型(多个基因的变化)有助于差异基线饮酒。我们的目标是 1) 开发和优化蛋白质组学方法 对丰富的大脑部分进行定量分析,2) 识别基线的整体差异 两种动物模型[AC7转基因模型(AC7 转基因与野生型)和HAP/LAP选择性育种模型(HAP与LAP)],以及3)在WID-2BC期间的选定时间点全面比较动物之间蛋白质表达的纵向变化(AC7转基因与野生型以及HAP与LAP)识别导致差异和过度饮酒行为的蛋白质。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christine C Wu其他文献

Christine C Wu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christine C Wu', 18)}}的其他基金

A Triple Quadrupole Mass Spectrometer for the INIA-West Consortium
INIA-West 联盟的三重四极杆质谱仪
  • 批准号:
    8136847
  • 财政年份:
    2010
  • 资助金额:
    $ 24.11万
  • 项目类别:
Proteomic Dissection of Withdrawal-Induced Excessive Drinking
戒断引起的过度饮酒的蛋白质组学解析
  • 批准号:
    7814528
  • 财政年份:
    2009
  • 资助金额:
    $ 24.11万
  • 项目类别:
Quantitative Proteomic Analysis of Alcoholic Fatty Liver Biogenesis
酒精性脂肪肝生物发生的定量蛋白质组学分析
  • 批准号:
    7085628
  • 财政年份:
    2006
  • 资助金额:
    $ 24.11万
  • 项目类别:
Proteomic Dissection of Withdrawal-Induced Excessive Drinking
戒断引起的过度饮酒的蛋白质组学解析
  • 批准号:
    7214480
  • 财政年份:
    2006
  • 资助金额:
    $ 24.11万
  • 项目类别:
Proteomic Tools for the Comprehensive Analysis of Dopamine Transporter Topology
用于多巴胺转运蛋白拓扑综合分析的蛋白质组学工具
  • 批准号:
    7135141
  • 财政年份:
    2006
  • 资助金额:
    $ 24.11万
  • 项目类别:
Quantitative Proteomic Analysis of Alcoholic Fatty Liver Biogenesis
酒精性脂肪肝生物发生的定量蛋白质组学分析
  • 批准号:
    7812141
  • 财政年份:
    2006
  • 资助金额:
    $ 24.11万
  • 项目类别:
Quantitative Proteomic Analysis of Alcoholic Fatty Liver Biogenesis
酒精性脂肪肝生物发生的定量蛋白质组学分析
  • 批准号:
    7614372
  • 财政年份:
    2006
  • 资助金额:
    $ 24.11万
  • 项目类别:
Quantitative Proteomic Analysis of Alcoholic Fatty Liver Biogenesis
酒精性脂肪肝生物发生的定量蛋白质组学分析
  • 批准号:
    7234011
  • 财政年份:
    2006
  • 资助金额:
    $ 24.11万
  • 项目类别:
Proteomic Dissection of Withdrawal-Induced Excessive Drinking
戒断引起的过度饮酒的蛋白质组学解析
  • 批准号:
    7483228
  • 财政年份:
    2006
  • 资助金额:
    $ 24.11万
  • 项目类别:
Proteomic Dissection of Withdrawal-Induced Excessive Drinking
戒断引起的过度饮酒的蛋白质组学解析
  • 批准号:
    8239873
  • 财政年份:
    2006
  • 资助金额:
    $ 24.11万
  • 项目类别:

相似海外基金

Sex Specific Effects of Adolescent Alcohol Exposure on BNST Plasticity
青少年酒精暴露对 BNST 可塑性的性别特异性影响
  • 批准号:
    10836173
  • 财政年份:
    2023
  • 资助金额:
    $ 24.11万
  • 项目类别:
PPARdelta receptors and alcohol use phenotypes
PPARδ 受体和饮酒表型
  • 批准号:
    10682348
  • 财政年份:
    2023
  • 资助金额:
    $ 24.11万
  • 项目类别:
Genomics of Alcohol Withdrawal and Treatment Response to Benzodiazepines
酒精戒断的基因组学和苯二氮卓类药物的治疗反应
  • 批准号:
    10497622
  • 财政年份:
    2023
  • 资助金额:
    $ 24.11万
  • 项目类别:
Oprk1-regulated neurocircuitry and phenotypes of alcohol use disorder
Oprk1 调节的神经回路和酒精使用障碍的表型
  • 批准号:
    10753867
  • 财政年份:
    2023
  • 资助金额:
    $ 24.11万
  • 项目类别:
Ketamine for the treatment for alcohol use disorder in the emergency department: A pilot double-blind, placebo-controlled randomized clinical trial
氯胺酮在急诊科治疗酒精使用障碍:一项双盲、安慰剂对照随机临床试验
  • 批准号:
    10593244
  • 财政年份:
    2022
  • 资助金额:
    $ 24.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了